Angelos Stergiou: a blend of medicine, research and business

Dr. Angelos M. Stergiou, MD, ScD h.c. is CEO and Vice Chairman of the company behind the WT1 cancer vaccine, SELLAS Life Sciences Group. Prior to founding the company, Dr. Stergiou had worked in a number of positions in biotechnology and pharmaceutical companies in Europe and the United States. Today, he is enjoying his work in the biotechnology sector, a passion of his. In reference to founding SELLAS Life Sciences, he said:

“It combines medicine, research and business, and I truly love doing this every day.” He went on to state: “The thirst to get to the finish line and get [the WT1 cancer vaccine] approved, so we can potentially save lives, is breathtaking.”

Visit https://angelosstergiou.wordpress.com/about-angelos-stergiou to know more bout him.

Advertisements

About Angelos Stergiou

Dr. Angelos M. Stergiou, MD, ScD h.c. is shaping the world through biotechnology, and you could too.
This entry was posted in Angelos Stergiou and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s